Zogenix has bounced back from the FDA’s rejection of its only drug, with the acquisition of Modis Therapeutics and a developmental rare disease drug that has already been championed by regulators in ...

Akums Drugs stock rallied 3.73 percent to Rs 443.15 on Monday, extending upward journey for third consecutive session and trading above the upper Bollinger bands.

History has been profoundly unfair to the Matuas, who have endured over a century of communal violence and persecution in Bengal ...

Download Indian Rupee stock data: historical USDINR stock prices from MarketWatch.

The Trump administration on Tuesday imposed visa bans on a former European Union commissioner and anti-disinformation campaigners it says were involved in censoring U.S. social media platforms, in the ...

Kiren Rijiju Slams Rahul Gandhi's Remarks in US: "Shows His Immaturity" EAM S Jaishankar Hints at Potential Disruptive Political Changes in Bangladesh Independence Day 2024: Why Pakistan celebrates ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Eric's career includes extensive work ...